Health-related quality of life in children with chronic immune thrombocytopenia in China

Health and Quality of Life Outcomes

Volumn 14, Issue 1, 2016, Pages

  Zhang, Heng ^a   Wang, Li ^b   Quan, Meijie ^b   Huang, Jie ^a   Wu, Peng ^a   Lu, Qin ^a   Fang, Yongjun ^a  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Children's Hospital of Hebei Province   (China)

Author keywords

Health RELATED QUALITY OF life (HRQoL); Immune thrombocytopenia (ITP); The Kids'ITP Tools (KIT); The pediatric quality of life inventory (PedsQL )

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW EXAMINATION; CHILD; CHINA; CHRONIC DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; DISEASE ASSESSMENT; DISEASE DURATION; DRUG USE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTERNAL CONSISTENCY; KIDS IMMUNE THROMBOCYTOPENIA TOOL QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEDIATRIC QUALITY OF LIFE INVENTORY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RELIABILITY; SELF REPORT; MIDDLE AGED; PARENT; PRESCHOOL CHILD; PSYCHOLOGY; PSYCHOMETRY; QUESTIONNAIRE; REPRODUCIBILITY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHINA; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARENTS; PSYCHOMETRICS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SELF REPORT; SURVEYS AND QUESTIONNAIRES;

EID: 85007504318     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-016-0445-3     Document Type: Article

References (30)

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995-1008.
2. George JN. Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost. 2006;4:1664-72.
3. Gernsheimer T. Epidemiology and pathophysiology of immune thrombocytopenic purpura. Eur J Haematol Suppl. 2008;3-8.
4. Heitink-Polle KM, Haverman L, Annink KV, Schep SJ, de Haas M, Bruin MC. Health-related quality of life in children with newly diagnosed immune thrombocytopenia. Haematologica. 2014;99:1525-31.
5. Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Pediatr Clin North Am. 2008;55:393-420. ix.
6. Yacobovich J, Revel-Vilk S, Tamary H. Childhood immune thrombocytopenia-who will spontaneously recover? Semin Hematol. 2013; 50 Suppl 1:S71-4.
7. Demircioglu F, Saygi M, Yilmaz S, Oren H, Irken G. Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol. 2009;26:526-32.
8. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386-93.
9. Imbach P, Kuhne T, Muller D, Berchtold W, Zimmerman S, Elalfy M, Buchanan GR. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer. 2006;46:351-6.
10. Neunert CE, Buchanan GR, Blanchette V, Barnard D, Young NL, Curtis C, Klaassen RJ. Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer. 2009;53:652-4.
11. Michel M. Immune thrombocytopenic purpura: epidemiology and implications for patients. Eur J Haematol Suppl. 2009;3-7.
12. Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther MA, American Society of H. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190-207.
13. McMillan R, Bussel JB, George JN, Lalla D, Nichol JL. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol. 2008;83:150-4.
14. Mathias SD, Gao SK, Miller KL, Cella D, Snyder C, Turner R, Wu A, Bussel JB, George JN, McMillan R, et al. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008;6:13.
15. Barnard D, Woloski M, Feeny D, McCusker P, Wu J, David M, Bussel J, Lusher J, Wakefield C, Henriques S, et al. Development of disease-specific healthrelated quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol. 2003;25:56-62.
16. Klaassen RJ, Blanchette VS, Barnard D, Wakefield CD, Curtis C, Bradley CS, Neufeld EJ, Buchanan GR, Silva MP, Chan AK, Young NL. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools. J Pediatr. 2007; 150:510-5. 515 e511.
17. Klaassen RJ, Blanchette V, Burke TA, Wakefield C, Grainger JD, Gaedicke G, Riedlinger A, Dufort G, Citrin E, Reguerre Y, et al. Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP tools. Pediatr Blood Cancer. 2013;60:95-100.
18. Varni JW, Burwinkle TM, Seid M. The PedsQL 4.0 as a school population health measure: feasibility, reliability, and validity. Qual Life Res. 2006;15:203-15.
19. Gheissari A, Farajzadegan Z, Heidary M, Salehi F, Masaeli A, Mazrooei A, Varni JW, Fallah Z, Zandieh F. Validation of Persian Version of PedsQL 4.0 Generic Core Scales in Toddlers and Children. Int J Prev Med. 2012;3:341-50.
20. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800-12.
21. Chan LF, Chow SM, Lo SK. Preliminary validation of the Chinese version of the pediatric quality of life inventory. Int J Rehabil Res. 2005;28:219-27.
22. Chen YM, He LP, Mai JC, Hao YT, Xiong LH, Chen WQ, Wu JN. Validity and reliability of pediatric quality of life inventory version 4.0 generic core scales in Chinese children and adolescents. Zhonghua Liu Xing Bing Xue Za Zhi. 2008;29:560-3.
23. Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, Neufeld EJ, Vesely SK, Adix L, Blanchette VS, Kuhne T, Intercontinental Childhood ITPSGRIIP. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008;112:4003-8.
24. Alam MM. Idiopathic thrombocytopenic purpura in children: a 10 years experience at tertiary care hospital. J Pak Med Assoc. 2014;64:1358-62.
25. Zilber R, Bortz AP, Yacobovich J, Yaniv I, Tamary H. Analysis of health-related quality of life in children with immune thrombocytopenia and their parents using the kids' ITP tools. J Pediatr Hematol Oncol. 2012;34:2-5.
26. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168-86.
27. Neunert CE. Current management of immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2013;2013:276-82.
28. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994; 96:115-23.
29. Grainger JD, Young NL, Blanchette VS, Klaassen RJ. Quality of life in immune thrombocytopenia following treatment. Arch Dis Child. 2013;98:895-7.
30. Strullu M, Rakotonjanahary J, Tarral E, Savagner C, Thomas C, Mechinaud F, Reguerre Y, Poignant S, Boutet A, Bassil J, et al. Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network. Health Qual Life Outcomes. 2013;11:193.